NCT02062255View on ClinicalTrials.gov

Impact of COX2 on Sera Biomarkers From Obese Subjects

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Breast Cancer Survivors
Interventions
DRUG

Aspirin

DIETARY_SUPPLEMENT

Omega 3 FFA

Trial Locations (1)

78229

Cancer Therapy and Research Center at UTHSCSA, San Antonio

All Listed Sponsors
lead

The University of Texas Health Science Center at San Antonio

OTHER

NCT02062255 - Impact of COX2 on Sera Biomarkers From Obese Subjects | Biotech Hunter | Biotech Hunter